The Brazil Ovarian Cancer Market size stood at USD xx million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Ovarian cancer is a type of cancer that begins in the ovaries. The female reproductive system contains two ovaries, one on each side of the uterus. Ovarian cancer often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ovarian cancer is more difficult to treat. Early-stage ovarian cancer, in which the disease is confined to the ovary, is more likely to be treated successfully. Surgery and chemotherapy are generally used to treat ovarian cancer.
The growth of ovarian cancer diagnostics market is enhanced by the rise in cases of ovarian cancer which further create a demand for introduction of improved testing technologies. Furthermore, family history of ovarian cancer is considered as positive indicator for the demand in diagnostics market. Factors such as an increase in the number of initiatives by SUS, brazil healthcare system and a rise in funding for ovarian cancer research are expected to drive the market.
Major Ovarian Cancer
Major types of ovarian cancer are Epithelial Cancer, Stromal Cancer, Germ Cell Tumor and Others. The type of ovarian cancer is determined by the location of developing cancerous cells. Epithelial tumors remained a forerunner in this segment, because it can be serious, mucinous, endometrioid, or clear cell. Most patients with epithelial cell carcinoma are diagnosed after the tumor has metastasized within the peritoneal cavity.
Germ cell and stromal cell tumors, collectively, capture a smaller share of this market. Stromal tumors develop in the tissues responsible for producing hormones such as estrogen, progesterone, and testosterone.